SAN DIEGO–(BUSINESS WIRE)–ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions potentially leading to anaphylaxis, has raised $20 milli… […]
SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL) (?Quidel?), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market Quidel?s… […]
Cisco has agreed to pay $660 million for Luxtera, a Caltech spinout that makes optical chips for data centers. The semiconductor company, founded in 2001, is based in Carlsbad, CA, a San Diego suburb. Cisco, the San Jose, CA-based tech giant (NASDAQ: C… […]
The pang of loneliness is far more prevalent than even the gloomiest of previous estimates, according to a new study from UC San Diego researchers. Three-fourths of Americans experience moderate to high levels of loneliness, said the study, publish… […]
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Cox?src=hash" target="_blank"gt;#Coxlt;/agt;–SCALE San Diego is partnering with US Ignite & the City of San Diego, with sponsorship from Cox Communications, to … […]
The science never stops at Sanford Burnham Prebys Medical Discovery Institute (SBP), and 2018 was no different.?
From an Alzheimer?s breakthrough to advancing promising medicines for pancreatic cancer and autoimmune disorders, our hardworking scientis… […]
SAN FRANCISCO & SACRAMENTO, Calif. & SAN DIEGO & WASHINGTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CEO?src=hash" target="_blank"gt;#CEOlt;/agt;–California Life Sciences Association (CLSA) Names Mike Gu… […]
SAN DIEGO–(BUSINESS WIRE)–YC-Backed Startup CB Therapeutics Adds ?Entourage-Effect? Terpenes to its Growing List of Sustainably Produced Cannabis Compounds […]
? With backing from Novo Holdings and a drug from AstraZeneca, Aristea Therapeutics is unveiling a $15 million Series A that will kickstart Phase II studies of its lead program, RIST4721. James Mackay, who used to run AstraZeneca-acquired Ardea Bioscie… […]
Seismic, an enterprise software company with ambitious growth plans, has raised $100 million in a Series E financing and added Microsoft chairman John W. Thompson to its board of directors. The venture investment, which the San Diego startup announced … […]
A year after steering cancer drug developer Ignyta into a $1.7 billion sale to Roche, Jonathan Lim is back at it again. Ignyta?s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to make new canc… […]
Jonathan Lim knows how to build biotechs for a sale. He auctioned off Ignyta ? where he was CEO ? to Roche last February for a tidy $1.7 billion, gaining a 74% premium on his stock. A few months before he also participated in the sale of Bonti to Aller… […]
SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Successfully Optimizes Manufacturing Process and Scale Up for AB-SA01 Clinical Development […]
Sophiris Bio said Monday that 10 patients who were administered its experimental prostate cancer drug a second time didn?t see any additional benefit. The news sent the San Diego, CA, and Vancouver, BC-based biotech?s stock plunging about 40 percent. S… […]
As a Harvard professor with close ties to MIT?s Bob Langer, Omid Farokhzad has enjoyed a high-profile role in the Boston/Cambridge biotech community, where he?s participated in launching a lineup of startups. And now Farokhzad ? whose accomplishments e… […]
Parisian venture capital firm Kurma Partners is raising the bar. It?had set its sights on its biggest-ever fund?? the Kurma Biofund III?? with a target of??150 million (about $170 million), backed by marquee investors including Servier, Bpifrance and I… […]
Will ?CBUS? and ?SI? join ?THOR? and ?RMED?? It?s next week or never (until 2019, that is) for two San Diego companies that have filed documents with securities regulators indicating plans to go public. Agtech company Cibus, which uses ?precision? gene… […]
MabVax Therapeutics says it doesn?t have enough money to continue funding its operations. The San Diego biotech company, which is testing an antibody discovery platform intended to speed products to patients with cancer and pancreatitis, said Thursday … […]
Since coding is fun to freshman Yuan Gao, creating his first word cloud from the Facebook page of Hal?c?o?lu Data Science Institute at UC San Diego was basically entertainment. He created the montage-style graph… […]
? Rheumatoid arthritis drug Olumiant?? approved for a narrower-than-expected patient population earlier this year to the dismay of its manufacturer Eli?Lilly $LLY and Incyte $INCY which had blockbuster dreams for the drug?? may be worth its weight in g… […]
? Rheumatoid arthritis drug Olumiant?? approved for a narrower-than-expected patient population earlier this year to the dismay of its manufacturer Eli?Lilly $LLY and Incyte $INCY which had blockbuster dreams for the drug?? may be worth its weight in g… […]
California?s groundbreaking stem cell agency is running low on time and money. The California Institute for Regenerative Medicine, or CIRM, is drawing down the last of $3 billion in state bond money granted by voters in 2004 with Proposition 71. Th… […]
California?s groundbreaking stem cell agency is running low on time and money. The California Institute for Regenerative Medicine, or CIRM, is drawing down the last of $3 billion in state bond money granted by voters in 2004 with Proposition 71. Th… […]
Reports + Research Local Biotech Venture Capital Update DealForma catalogues the largest local venture capital sources, including number and total of venture rounds.? Leading the pack for number of venture rounds are Avalon Ventures and Correlation Ven… […]
Reports + Research Local Biotech Venture Capital Update DealForma catalogues the largest local venture capital sources, including number and total of venture rounds.? Leading the pack for number of venture rounds are Avalon Ventures and Correlation Ven… […]
Completing a grand plan for a dual listing in Shanghai and Hong Kong in the span of seven months, WuXi AppTec has debuted on the HKEX, ending the day at its original IPO price.
Net proceeds will register at $967 million (HK $7,553 million), the company… […]
Copyright © 2026 Biotech Networks, LLC
